News Snapshot:
Unilever to continue acquisition move on GlaxoSmithKline health arm despite rejection Leading Fast Moving Consumer Goods (FMCG) Company, Unilever, has expressed determination to continue to pursue a deal to acquire the health arm of GlaxoSmithKline, a multinational pharmaceutical company. The consumer giant’s offer valued at £50bn was rejected by GlaxoSmithKline but the company is still resolute to see the acquisition bid scale through noting that the deal is a strong strategic fit for the company. GlaxoSmithKline said it received and rejected three unsolicited proposals from Unilever to acquire the GSK Consumer Healthcare business, including a late 2021 approach that valued...
